Skip to main content
Clinical Trials/NCT07158593
NCT07158593CompletedNot Applicable

Universal Prevention Program "Claudia Carraro" for Improving Body Image and Promoting Healthy Lifestyles in Adolescent Boys and Girls: a Cluster Randomized Controlled Trial With 24-week Follow-up

Villa Garda Hospital1 site in 1 country1,205 target enrollmentStarted: January 10, 2020Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
1,205
Locations
1
Primary Endpoint
Eating Disorder Examination Questionnaire

Study Overview

Brief Summary

This is a cluster randomized controlled trial with two assessment points (baseline and 24-week follow-up) comparing the Claudia Carraro prevention program to a no-intervention control group. The intervention group was also assessed at post-intervention. To ensure that all students benefit from the intervention, the control group received the intervention after the 24 weeks.

Randomization was performed at the school level, not the student level.

Detailed Description

Participants were recruited from January 2020 and December 2024. Secondary school administrators were contacted via telephone and/or email and provided with a letter outlining the core principles of the prevention program. If the school principal (or a designated representative) agreed to participate, they were asked to sign a formal agreement to take part in the intervention.

Students in the first or second year of upper secondary school and those who signed a written informed consent were included. Also, the informed consent should be signed by their parents. However, were excluded from the study students who self-reported diagnosis of an ED (these individuals could participate in the intervention but were excluded from data analysis).

Theoretical Framework The "Claudia Carraro" prevention program is grounded in a cognitive-behavioral conceptualization of the development of eating disorders or disordered eating. The program was designed to address specific and non-specific risk factors that appear relevant: body dissatisfaction and unhealthy weight control behaviors. Its dual objective is to help participants reduce the importance they place on body weight and shape in self-evaluation while simultaneously promoting healthy weight regulation through adherence to Mediterranean dietary guidelines and an active lifestyle.

The strategies and procedures used are derived from cognitive behavioral therapy protocols for eating disorders (Dalle Grave & Calugi, 2020). The intervention is delivered by psychologists specialized in eating and weight disorders using an interactive, rather than didactic, format, involving small group activities and assigned homework tasks between sessions.

Facilitator Training and Supervision Facilitators received formal training through a one-day seminar conducted by the principal and co-investigators. To assess adherence to the intervention protocol, all sessions were audio-recorded, and the program coordinators reviewed a random sample.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
11 Years to 19 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Students in the first or second year of upper secondary school
  • •Students who signed a written informed consent
  • •Informed consent signed by their parents

Exclusion Criteria

  • •Students who self-reported diagnosis of an eating disorder (these individuals could participate in the intervention but were excluded from data analysis)

Arms & Interventions

Intervention

Experimental

The intervention arm, includes studed who attended the "Claudia Carraro" prevention program. It is grounded in a cognitive-behavioral conceptualization of the development of eating disorders or disordered eating. The program was designed to address specific and non-specific risk factors that appear relevant: body dissatisfaction and unhealthy weight control behaviors. Its dual objective is to help participants reduce the importance they place on body weight and shape in self-evaluation while simultaneously promoting healthy weight regulation through adherence to Mediterranean dietary guidelines and an active lifestyle.

The strategies and procedures used are derived from cognitive behavioral therapy protocols for eating disorders (Dalle Grave & Calugi, 2020). The intervention is delivered by psychologists specialized in eating and weight disorders using an interactive, rather than didactic, format, involving small group activities and assigned homework tasks between sessions.

Intervention: Claudia carraro prevention program (Other)

Control

No Intervention

No intervention. The control group received the intervention after the 24 weeks

Outcomes

Primary Outcomes

Eating Disorder Examination Questionnaire

Time Frame: Baseline and 24-week follow-up. The intervention group was also assessed at post-intervention

The Eating Disorder Examination Questionnaire (EDE-Q) (Calugi et al., 2017; Fairburn et al., 2008) is a validated Italian version that assesses the severity of eating disorder psychopathology over the past 28 days. The EDE-Q assesses eating disorder psychopathology with a global score and four subscales (restraint, eating concern, weight concern, shape concern) and eating disorder behaviours (objective binge-eating, self-induced vomiting, laxative misuse, excessive exercise). Scores range from 0 to 6. Higher scores indicate higher eating disorder psychopathology.

Secondary Outcomes

  • Short Form of the International Physical Activity Questionnaire(Baseline and 24-week follow-up. The intervention group was also assessed at post-intervention)
  • Mediterranean Diet Adherence Questionnaire(Baseline and 24-week follow-up. The intervention group was also assessed at post-intervention)

Investigators

Sponsor
Villa Garda Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Riccardo Dalle Grave

Head of Nutrition and Endocrinology at Villa Garda Hospital

Villa Garda Hospital

Study Sites (1)

Loading locations...

Similar Trials

Completed
Phase 3
Extension Study to Evaluate the Safety and Efficacy of PT003, PT001, and PT005 in Subjects With Moderate to Very Severe COPD, With Spiriva® Handihaler® (PINNACLE 3)Chronic Obstructive Pulmonary Disease (COPD)
NCT01970878Pearl Therapeutics, Inc.892
Active, not recruiting
Not Applicable
Olpadronate intra venous in chronic low back paiMedDRA version: 18.1Level: LLTClassification code 10008837Term: Chronic back painSystem Organ Class: 100000004859non-specific Chronic Low Back Pain persisting for at least 3 months
EUCTR2015-004269-96-NLGador S.A.
Completed
Phase 2
A 24 weeks multicentre, randomized, double-blind, placebo-controlled, parallel group, study to evaluate the efficacy, safety and tolerability of intravenous IG-8801 20 mg and 40 mg in subjects with chronic low back paidegenerative afwijkingen van de lumbale wervelkolom leidend tot axiale aspecifieke en chronische lage rugpijnaspecific low back painchronic low back pain
NL-OMON46893Gador S.A.58
Terminated
Phase 2
ARMOR (Analyzing Renal Mechanisms of Creatinine Excretion in Patients On tesaglitazaR)Diabetes Mellitus, Type 2
NCT00229684AstraZeneca100
Active, not recruiting
Phase 1
Clinical Research Study to compare Umeclidinium/Vilanterol, Umeclidimium, and Salmeterol in subjects with chronic obstructive pulmonary disease (COPD).Chronic obstructive pulmonary disease (COPD)MedDRA version: 19.1 Level: PT Classification code 10009033 Term: Chronic obstructive pulmonary disease System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders
EUCTR2016-002513-22-FRGlaxoSmithKline Research & Development Ltd2,425